How to Use Free Wilson Analysis

Free Wilson Analysis is a classic structure-activity relationship method for congeneric small-molecule series built around a shared scaffold. The original Free-Wilson idea is that biological activity can be approximated as the sum of contributions from substituents at defined attachment positions, which makes the method attractive when medicinal chemists want interpretable R-group SAR rather than a black-box score.

On Neurosnap, researchers provide a Core Molecule that must be present in every analog and then list Input Molecules with experimental activity values such as pIC50. The workflow is designed for matched-series analysis, scaffold-constrained idea generation, and prioritization of analogs that recombine already observed substituents.

The result is more than a fitted model. It is an interpretable decomposition of the series into attachment-point effects that chemists can discuss directly when planning the next synthesis set.

The classical Free-Wilson formulation decomposes each compound into binary indicators for which R-groups are present at each substitution position and then estimates the contribution of each substituent to activity. That additive model is most appropriate when the series shares one core and when SAR is dominated by substituent swaps rather than major scaffold changes.

On Neurosnap, the series is aligned to the supplied core, transformed into an R-group design matrix, and summarized through predicted product tables, R-group coefficient tables, one-hot encodings, and core summaries. These views help researchers identify which positions drive potency, which substituents look favorable or unfavorable, and which unmade combinations are worth considering next.

Free Wilson analysis works best as an interpretable medicinal-chemistry planning tool. It is especially useful when a team wants to rationalize a congeneric series and choose the next analogs from already observed fragments rather than move immediately to a more opaque QSAR model.

• Scaffold-aware input: Requiring a shared core keeps the analysis aligned with real congeneric medicinal-chemistry series.
• Interpretable substituent effects: R-group coefficients show which attachment points and substituents contribute positively or negatively to activity.
• Designed-for-chemist output: Predicted products and one-hot tables help connect the fitted model back to real analog ideas.
• Useful synthesis planning: The workflow can highlight unmade R-group combinations that are worth testing next.